Key Takeaways Oral GLP-1 receptor agonists are now the primary areas of innovation with the promise of giving patients a more practical alternative to injectable obesity therapies and, hopefully, higher rates of long-term adherence growing from $1.95 billion revenue in 2025 to account for more than 48% of the market by 2035
Let us recall in our biology class, what is a peptide
These medications mimic natural gut hormones, leading to: Reduced hunger and cravings , making portion control easier
Why do I feel colder on a meat-only diet
Cosmed Group Inc., a medical and food sterilization company, has filed for Chapter 11 bankruptcy protection following a wave of lawsuits alleging its use of ethylene oxide (EtO) caused cancer and other serious health conditions
Its skincare with a twist because who said glowing up cant be fun